Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Apr 19.
Published in final edited form as: Org Lett. 2013 Apr 4;15(8):1994–1997. doi: 10.1021/ol4006689

A General Synthetic Approach to Functionalized Dihydrooxepines

K C Nicolaou 1,*, Ruocheng Yu 1, Lei Shi 1, Quan Cai 1,, Min Lu 1, Philipp Heretsch 1
PMCID: PMC3653422  NIHMSID: NIHMS464022  PMID: 23550898

Abstract

graphic file with name nihms464022u1.jpg

A three-step sequence to access functionalized 4,5-dihydrooxepines from cyclohexenones has been developed. This approach features a regioselective Baeyer–Villiger oxidation and subsequent functionalization via the corresponding enol phosphate intermediate.


4,5-Dihydrooxepines are featured as structural motifs within various natural products, ranging from sesquiterpenes, such as miscandenin1 and endiadric acid derivative beilshmiedin, 2 to polyketides, such as conioxepinol A3 (Figure 1). This framework is also found in some of the most interesting members of the epidithiodiketopiperazine family as represented by aranotin 4 (Figure 1). Consequently, a number of approaches have been developed to access this structural motif. These include acid-catalyzed cyclization, 5 Rh-catalyzed cycloisomerization, 6 ring-closing metathesis, 7 [4+2] cycloaddition/epoxidation/retro [4+2] cycloaddition, 8 Cope rearrangement, 9 fragmentation, 10 and Criegee rearrangement.11

Figure 1.

Figure 1

Selected natural products containing the 4,5-dihydrooxepine structural motif.

Despite this progress, the synthesis of related natural products in which the dihydrooxepine unit is highly functionalized remains challenging, in part because the scope and generality of existing methods are rather limited. Post-functionalization of pre-formed dihydrooxepines is also difficult due to the sensitive nature of these structural moieties. Therefore, a general approach through which substrates with a diverse array of substitution patterns can be reliably transformed into functionalized dihydrooxepines is highly desirable.

As part of our continuing efforts toward the total synthesis of members of the dihydrooxepine epidithiodiketopiperazine family,8a,12 we opted to develop a method to synthesize 4,5-dihydrooxepines from cyclohexenones. Such a strategy would benefit from the ready availability of functionalized cyclohexenones, thus allowing access to a broad range of dihydrooxepine structures. We reasoned that ring expansion of the cyclohexenone could be achieved through a regioselective Baeyer–Villiger oxidation. Further functionalization of the resulting enol lactone through either reduction or C–C bond formation would give rise directly to the bis-enol ether moiety found in 4,5-dihydrooxepines (Figure 2).13

Figure 2.

Figure 2

Proposed synthesis of functionalized 4,5-dihydrooxepines from the corresponding cyclohexenones.

Our experimentation began with the Baeyer–Villiger oxidation of enone 1a (Table 1). Thus, reaction of 1a with mCPBA gave the desired enol lactone as a single regioisomer, albeit in low conversion (Table 1, entry 1). Attempts to use stronger oxidants such as CF3CO3H led to partial decomposition of the product (entry 2). We then reasoned that substrate activation by a suitable Lewis acid would improve conversion under milder reaction conditions that would avoid product decomposition. Indeed, the combination of SnCl4 and bis(trimethylsilyl)peroxide (BTSP), in the presense of trans-1,2-diaminocyclohexane (ligand A), generated the desired product 2a in 83% yield (entry 3).14 The use of this ligand proved to be critical as it successfully tempered the Lewis acidity of SnCl4. Neither SnCl4 itself nor its combination with other ligands tested, such as trans-1,2-di(tosylamino)cyclohexane (ligand B), led to comparable yields (entries 4–6). The presence of dry molecular sieves was essential for the success of this reaction, as in its absence, only trace amounts of the product was observed (entry 7).

Table 1.

Study of the Baeyer–Villiger Oxidation of Enonesa

graphic file with name nihms464022u2.jpg
entry conditions yield (%)b
1c mCPBA, CH2Cl2 15
2c UHP, TFAA, CH2Cl2 decomp.
3c BTSP, SnCl4, ligand A, 4 Å MS, CH2Cl2 83
4d BTSP, SnCl4, 4 Å MS, CH2Cl2 trace
5d BTSP, SnCl4, ligand B, 4 Å MS, CH2Cl2 22
6d BTSP, SnCl4, pyridine, 4 Å MS, CH2Cl2 32
7d BTSP, SnCl4, ligand A, CH2Cl2 trace
a

Reactions were carried out on 0.25 mmol scale.

b

1H NMR yield.

c

Reactions were carried out at 0.1 M concentration with 0.5 equiv of SnCl4, 0.5 equiv of ligand A, 3.0 equiv of BTSP and 50 mg 4 Å MS at 25 °C.

d

Reactions were carried out under the identical conditions in entry 3 with changes indicated in the table.

mCPBA = meta-chloroperoxybenzoic acid, UHP = urea hydrogen peroxide, TFAA = trifluoroacetic anhydride, BTSP = bis(trimethylsilyl)peroxide.

Conversion of the Baeyer–Villiger product 2a to the corresponding enol phosphate 3a went smoothly under our previously developed conditions (Scheme 1).15 The phosphate group was chosen over the more common triflate group because the former is well-known to be more stable than the latter.15

Scheme 1.

Scheme 1

Enol Phosphate Formation and Pd-Catalyzed Reduction to 4,5-Dihydrooxepine

Pd-catalyzed reduction of the diphenyl phosphate 3a proved to be unsuccessful when using either Ph2SiH2 or nBu3SnH as the reducing agent. After extensive screening, Et3Al turned out to be the optimal reducing agent, giving the desired 4,5-dihydrooxepine 4a in 81% yield (Scheme 1). However, when applying the same reduction conditions to phosphate 3b (Table 2), we obtained an inseparable mixture of the desired product 4b and the ethylated product 5b in ca. 3:2 ratio (Table 2, entry 1). This result reflects the competition between β-hydride elimination and reductive elimination of the ethylated intermediate (see Table 2). 16 Attempts to optimize the reduction of 3b by changing the solvent (entry 2) or using the diethyl phosphate 3b′ (entry 3) gave a mixture of 4b and 5b, albeit in different ratios (see Table 2). We then turned to some other reducing agents and found that LiBH4 proved to be the best, giving exclusively the benzodihydrooxepine 4b in good yield [entries 4 (66% yield) and 5 (67% yield)].

Table 2.

Optimization of Enol Phosphate Reductiona

graphic file with name nihms464022u3.jpg
entry R reducing agent solvent yield (%)b (4b+5b) 4b:5bc
1 Ph Et3Al ClCH2CH2Cl 58 60:40
2 Ph Et3Al CH2Cl2 62 37:63
3 Et Et3Al ClCH2CH2Cl 70 90:10
4 Et LiBH4 THF 66 4b only
5 Ph LiBH4 THF 67 4b only
a

Reactions were run on 0.1 mmol scale at 0.05 M concentration with 0.2 equiv of Pd(PPh3)4 and 2.5 equiv of Et3Al at 25 °C or 10 equiv of LiBH4 at 0 °C.

b

1H NMR yield.

c

Ratios determined by 1H NMR spectroscopic analysis.

With the developed optimized conditions in hand, we then proceeded to assess the generality and scope of this three-step procedure to functionalized dihydrooxepines. As shown in Table 3, a variety of substrates with diverse substitution patterns and functional groups could be reliably transformed into the corresponding 4,5-dihydrooxepines. Cyclohexenones with either a methyl group on the olefinic bond (entries 3 and 5) or gem-dimethyl groups on the 4-position (entry 4) are good substrates for these transformation, although the latter exhibits lower reactivity in the first and third steps as compared to the others. Functional groups such as an isolated olefinic bond, an electron-rich arene, a TBS-protected secondary alcohol, or a ketal group are all tolerated in these procedures (entries 5–8). Most notably, the current method is also applicable to relatively complex structures, including the protected Wieland-Miescher ketone 1h and the cholesterol derivative 1i (entries 8 and 9, respectively). Thus, application of the present method to these substrates allows rapid access to the relatively complex dihydrooxepines 4h and 4i, respectively.

Table 3.

Scope and Generality of the 4,5-Dihydrooxepine-Forming Sequencea

entry substrate lactone (% yield)b enol phosphate (% yield)b 4,5-dihydrooxepine (% yield)b
1 graphic file with name nihms464022t1.jpg
1a
graphic file with name nihms464022t2.jpg
2a (83)
graphic file with name nihms464022t3.jpg
3a (92)
graphic file with name nihms464022t4.jpg
4a (81)c
2 graphic file with name nihms464022t5.jpg
1b
graphic file with name nihms464022t6.jpg
2b (70)
graphic file with name nihms464022t7.jpg
3b (93)
graphic file with name nihms464022t8.jpg
4b (67)d,e
3 graphic file with name nihms464022t9.jpg
1c
graphic file with name nihms464022t10.jpg
2c (72)
graphic file with name nihms464022t11.jpg
3c (89)
graphic file with name nihms464022t12.jpg
4c (90)c
4 graphic file with name nihms464022t13.jpg
1d
graphic file with name nihms464022t14.jpg
2d (70)
graphic file with name nihms464022t15.jpg
3d (55)
graphic file with name nihms464022t16.jpg
4d (81)c
5 graphic file with name nihms464022t17.jpg
1e
graphic file with name nihms464022t18.jpg
2e (74)e
graphic file with name nihms464022t19.jpg
3e (84)
graphic file with name nihms464022t20.jpg
4e (61)d,e
6 graphic file with name nihms464022t21.jpg
1f
graphic file with name nihms464022t22.jpg
2f [34 (46 brsm)]f
graphic file with name nihms464022t23.jpg
3f (75)
graphic file with name nihms464022t24.jpg
4f (64)d,e
7 graphic file with name nihms464022t25.jpg
1g
graphic file with name nihms464022t26.jpg
2g (79)
graphic file with name nihms464022t27.jpg
3g (83)
graphic file with name nihms464022t28.jpg
4g (86)d
8 graphic file with name nihms464022t29.jpg
1h
graphic file with name nihms464022t30.jpg
2h (54)
graphic file with name nihms464022t31.jpg
3h (90)
graphic file with name nihms464022t32.jpg
4h (71)d
9 graphic file with name nihms464022t33.jpg
1i
graphic file with name nihms464022t34.jpg
2i (99)
graphic file with name nihms464022t35.jpg
3i (57)
graphic file with name nihms464022t36.jpg
4i (82)d
a

Lactone formation: reactions were carried out on 1.0 mmol scale at 0.1 M concentration in CH2Cl2 with 0.5 equiv of SnCl4, 0.5 equiv of ligand A, 3.0 equiv of BTSP and 200 mg 4 Å MS at 25 °C; enol phosphate formation: reactions were carried out on 0.5 mmol scale at 0.1 M concentration in THF with 2.0 equiv of KHMDS, 2.0 equiv of (PhO)2P(O)Cl, 3.0 equiv of HMPA at −78 °C; dihydrooxepine formation (method A): reactions were carried out on 0.2 mmol scale at 0.05 M concentration in ClCH2CH2Cl with 0.2 equiv of Pd(PPh3)4 and 2.5 equiv of Et3Al; dihydrooxepine formation (method B): reactions were carried out on 0.2 mmol scale at 0.05 M concentration in THF with 0.2 equiv of Pd(PPh3)4 and 10 equiv of LiBH4 at 0 °C.

b

Isolated yield unless otherwise noted.

c

Using method A.

d

Using method B.

e

Due to the volatility of the product, the yield refers to 1H NMR yield.

f

Anhydrous K2CO3 (200 mg) was added.

brsm = based on recovered starting material.

In addition to the above Pd-catalyzed reduction, the enol phosphate intermediate also provides a platform for a series of C–C bond forming reactions, thereby allowing further functionalization of the dihydrooxepine system. Thus, as demonstrated in Scheme 2, 3b could be successfully engaged in Ni-catalyzed Negishi (conditions a) and Kumada couplings (conditions b), leading to the corresponding alkyl-substituted products 5b and 6b, respectively, without competition from the β-hydride elimination pathway. Introduction of phenyl (conditions c), 3-thienyl (conditions d) and alkylnyl (conditions f) substituents can also be achieved in high yields using PdCl2(dppf) as the catalyst (products 7b, 8b and 10b, respectively). The same catalyst is also effective in converting the phosphate into an ester group (conditions e), albeit in moderate yield (product 9b).

Scheme 2.

Scheme 2

Functionalization of the 4,5-Dihydrooxepine Structural Motif via the Corresponding Enol Phosphate

In summary, we have developed a three-step approach for the synthesis of functionalized dihydrooxepines from readily available cyclohexenones. This sequence features a regioselective Baeyer–Villiger oxidation, subsequent enol phosphate formation and Pd-catalyzed functionalization. The large variety of available cyclohexenones provides the basis for the generality of this approach, while the mildness of reaction conditions ensures their reliable transformation to functionalized dihydrooxepines with minimal loss due to facile decomposition. The current method holds considerable promise for application to the synthesis of bioactive natural products and their analogs.

Supplementary Material

1_si_001

Acknowledgments

Financial support for this work was provided by the National Science Foundation (grant CHE-1243661) and the National Institutes of Health, USA (grant AI 055475).

Footnotes

Supporting Information Available: Experimental procedures, characterization and spectroscopic data for new compounds. This material is free of charge via the Internet at http://pubs.acs.org.

References

  • 1.Herz W, Subramaniam PS, Santhanam PS, Aota K, Hall AL. J Org Chem. 1970;35:1453. doi: 10.1021/jo00830a043. [DOI] [PubMed] [Google Scholar]
  • 2.Chouna JR, Nkeng-Efouet PA, Lenta BN, Wensi JD, Kimbu SF, Sewald N. Phytochemistry Lett. 2010;3:13. [Google Scholar]
  • 3.Wang Y, Zheng Z, Liu S, Zhang H, Li E, Guo L, Che Y. J Nat Prod. 2010;73:920. doi: 10.1021/np100071z. [DOI] [PubMed] [Google Scholar]
  • 4.Nagarajan R, Huckstep LL, Lively DH, Delong DC, Marsh MM, Neuss N. J Am Chem Soc. 1968;90:2980. [Google Scholar]
  • 5.(a) Peng J, Clive DLJ. J Org Chem. 2009;74:513. doi: 10.1021/jo802344t. [DOI] [PubMed] [Google Scholar]; (b) Peng J, Clive DLJ. Org Lett. 2007;9:2939. doi: 10.1021/ol071147z. [DOI] [PubMed] [Google Scholar]
  • 6.Codelli JA, Puchlopek ALA, Reisman SE. J Am Chem Soc. 2012;134:1930. doi: 10.1021/ja209354e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.(a) Gross U, Nieger M, Bräse S. Chem Eur J. 2010;16:11624. doi: 10.1002/chem.201001169. [DOI] [PubMed] [Google Scholar]; (b) Fustero S, Sánchez-Roselló M, Jiménez D, Sanz-Cervera JF, del Pozo C, Aceña JL. J Org Chem. 2006;71:2706. doi: 10.1021/jo0525635. [DOI] [PubMed] [Google Scholar]
  • 8.(a) Nicolaou KC, Lu M, Totokotsopoulos S, Heretsch P, Giguère D, Sun YP, Sarlah D, Nguyen TH, Wolf IC, Smee DF, Day CW, Bopp S, Winzeler EA. J Am Chem Soc. 2012;134:17320. doi: 10.1021/ja308429f. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Marx JN, Ajlouni A. Nat Prod Commun. 2010;5:5. [PubMed] [Google Scholar]
  • 9.(a) Xu X, Hu WH, Zavalij PY, Doyle MP. Angew Chem Int Ed. 2011;50:11152. doi: 10.1002/anie.201105557. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Shimizu M, Fujimoto T, Liu X, Takeda Y, Hiyama T. Heterocycles. 2008;76:329. [Google Scholar]; (c) Shimizu M, Fujimoto T, Liu X, Hiyama T. Chem Lett. 2004;33:438. [Google Scholar]; (d) Chou WN, White JB, Smith WB. J Am Chem Soc. 1992;114:4658. [Google Scholar]; (e) Clark DL, Chou WN, White JB. J Org Chem. 1990;55:3975. [Google Scholar]; (f) Aitken RA, Cadogan JIG, Gosney I, Hamill BJ, McLaughlin LM. J Chem Soc, Chem Commun. 1982:1164. [Google Scholar]
  • 10.Leyhane AJ, Snapper ML. Org Lett. 2006;8:5183. doi: 10.1021/ol061682j. [DOI] [PubMed] [Google Scholar]
  • 11.(a) Goodman RM, Kishi Y. J Org Chem. 1994;59:5125. [Google Scholar]; (b) Lu T, Vargas D, Fischer NH. Phytochemistry. 1993;34:737. doi: 10.1016/0031-9422(94)00625-4. [DOI] [PubMed] [Google Scholar]
  • 12.(a) Nicolaou KC, Giguère D, Totokotsopoulos S, Sun Y. Angew Chem, Int Ed. 2012;51:728. doi: 10.1002/anie.201107623. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Nicolaou KC, Totokotsopoulos S, Giguère D, Sun Y. J Am Chem Soc. 2011;133:8150. doi: 10.1021/ja2032635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.In their elegant synthesis of acetylaranotin, Tokuyama et al. prepared the 4,5-dihydrooxepine structural motif of the molecule from a lactone via the corresponding enol triflate; see: Fujiwara H, Korugi T, Okaya S, Okano K, Tokuyama H. Angew Chem, Int Ed. 2012;51:13062. doi: 10.1002/anie.201207307.
  • 14.Götlich R, Yamakoshi K, Sasai H, Shibasaki M. Synlett. 1997:971. [Google Scholar]
  • 15.Nicolaou KC, Shi GQ, Gunzner JL, Gärtner P, Yang Z. J Am Chem Soc. 1997;119:5467. [Google Scholar]
  • 16.Sato M, Takai K, Oshima K, Nozaki H. Tetrahedron Lett. 1981;22:1609. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1_si_001

RESOURCES